Does THIOTEPA Cause Chronic graft versus host disease? 192 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 192 reports of Chronic graft versus host disease have been filed in association with THIOTEPA (Thiotepa). This represents 2.8% of all adverse event reports for THIOTEPA.
192
Reports of Chronic graft versus host disease with THIOTEPA
2.8%
of all THIOTEPA reports
67
Deaths
45
Hospitalizations
How Dangerous Is Chronic graft versus host disease From THIOTEPA?
Of the 192 reports, 67 (34.9%) resulted in death, 45 (23.4%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Chronic graft versus host disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 192 reports have been filed with the FAERS database.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Acute graft versus host disease (331)
Cytomegalovirus infection reactivation (325)
What Other Drugs Cause Chronic graft versus host disease?
CYCLOSPORINE (1,012)
MYCOPHENOLATE MOFETIL (848)
METHOTREXATE (708)
TACROLIMUS (659)
CYCLOPHOSPHAMIDE (531)
FLUDARABINE (420)
RUXOLITINIB (321)
BUSULFAN (309)
PREDNISONE (251)
RITUXIMAB (244)
Which THIOTEPA Alternatives Have Lower Chronic graft versus host disease Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE